256 related articles for article (PubMed ID: 19534712)
21. Oral colon-specific drug delivery of protein and peptide drugs.
Sinha V; Singh A; Kumar RV; Singh S; Kumria R; Bhinge J
Crit Rev Ther Drug Carrier Syst; 2007; 24(1):63-92. PubMed ID: 17430100
[TBL] [Abstract][Full Text] [Related]
22. Designing oral vaccines targeting intestinal dendritic cells.
Devriendt B; De Geest BG; Cox E
Expert Opin Drug Deliv; 2011 Apr; 8(4):467-83. PubMed ID: 21375470
[TBL] [Abstract][Full Text] [Related]
23. Advancedoral vaccine delivery strategies for improving the immunity.
Zhang Y; Li M; Du G; Chen X; Sun X
Adv Drug Deliv Rev; 2021 Oct; 177():113928. PubMed ID: 34411689
[TBL] [Abstract][Full Text] [Related]
24. Models to predict intestinal absorption of therapeutic peptides and proteins.
Antunes F; Andrade F; Ferreira D; Nielsen HM; Sarmento B
Curr Drug Metab; 2013 Jan; 14(1):4-20. PubMed ID: 21933113
[TBL] [Abstract][Full Text] [Related]
25. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.
Kwon KC; Verma D; Singh ND; Herzog R; Daniell H
Adv Drug Deliv Rev; 2013 Jun; 65(6):782-99. PubMed ID: 23099275
[TBL] [Abstract][Full Text] [Related]
26. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
Yamamoto A; Ukai H; Morishita M; Katsumi H
Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
[TBL] [Abstract][Full Text] [Related]
27. Transgenic plant-based oral vaccines.
Lugade AA; Kalathil S; Heald JL; Thanavala Y
Immunol Invest; 2010; 39(4-5):468-82. PubMed ID: 20450287
[TBL] [Abstract][Full Text] [Related]
28. Implication of nanoparticles/microparticles in mucosal vaccine delivery.
Vyas SP; Gupta PN
Expert Rev Vaccines; 2007 Jun; 6(3):401-18. PubMed ID: 17542755
[TBL] [Abstract][Full Text] [Related]
29. Bioadhesive delivery systems for mucosal vaccine delivery.
Baudner BC; O'Hagan DT
J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
[TBL] [Abstract][Full Text] [Related]
30. Optimizing efficacy of mucosal vaccines.
Gebril A; Alsaadi M; Acevedo R; Mullen AB; Ferro VA
Expert Rev Vaccines; 2012 Sep; 11(9):1139-55. PubMed ID: 23151169
[TBL] [Abstract][Full Text] [Related]
31. Oral delivery of peptide drugs: barriers and developments.
Hamman JH; Enslin GM; Kotzé AF
BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
[TBL] [Abstract][Full Text] [Related]
32. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
Marasini N; Kaminskas LM
Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
[TBL] [Abstract][Full Text] [Related]
33. Oral peptide and protein delivery: intestinal obstacles and commercial prospects.
Smart AL; Gaisford S; Basit AW
Expert Opin Drug Deliv; 2014 Aug; 11(8):1323-35. PubMed ID: 24816134
[TBL] [Abstract][Full Text] [Related]
34. Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.
Vyas SP; Venugopalan P; Sood A; Mysore N
Pharmazie; 1997 May; 52(5):339-45. PubMed ID: 9183784
[TBL] [Abstract][Full Text] [Related]
35. Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies.
Shalaby WS
Clin Immunol Immunopathol; 1995 Feb; 74(2):127-34. PubMed ID: 7828366
[TBL] [Abstract][Full Text] [Related]
36. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
[TBL] [Abstract][Full Text] [Related]
37. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
Lawson LB; Norton EB; Clements JD
Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
[TBL] [Abstract][Full Text] [Related]
38. [Improvement of transmucosal absorption of biologically active peptide drugs].
Yamamoto A
Yakugaku Zasshi; 2001 Dec; 121(12):929-48. PubMed ID: 11766407
[TBL] [Abstract][Full Text] [Related]
39. Mucosal Lactobacillus vectored vaccines.
Yu Q; Zhu L; Kang H; Yang Q
Hum Vaccin Immunother; 2013 Apr; 9(4):805-7. PubMed ID: 23322214
[TBL] [Abstract][Full Text] [Related]
40. Delivery strategies to enhance mucosal vaccination.
Chadwick S; Kriegel C; Amiji M
Expert Opin Biol Ther; 2009 Apr; 9(4):427-40. PubMed ID: 19344280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
